Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 629548
                    [Title] => Hibiscus tea lowers BP in clinical trial
                    [Summary] => 
Quaffing three cups of hibiscus tea daily for six weeks resulted in a mean 7.2-mm Hg reduction in systolic blood pressure in mildly hypertensive or prehypertensive adults in a randomized, double-blind, placebo-controlled trial.
                    [DatePublished] => 2010-11-14 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

NATIONAL HIGH BLOOD PRESSURE EDUCATION PROGRAM COORDINATING COMMITTEE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 629548
                    [Title] => Hibiscus tea lowers BP in clinical trial
                    [Summary] => 
Quaffing three cups of hibiscus tea daily for six weeks resulted in a mean 7.2-mm Hg reduction in systolic blood pressure in mildly hypertensive or prehypertensive adults in a randomized, double-blind, placebo-controlled trial.
                    [DatePublished] => 2010-11-14 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Hibiscus tea lowers BP in clinical trial

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 14, 2010 - 12:00am

Quaffing three cups of hibiscus tea daily for six weeks resulted in a mean 7.2-mm Hg reduction in systolic blood pressure in mildly hypertensive or prehypertensive adults in a randomized, double-blind, placebo-controlled...

Opinion